Regulated Information
Full-year 2023 results - Presentation
Financial presentations3.06 MB • March, 7th 2024
Full-year 2023 results - Press release
Financial releases337.45 KB • March, 7th 2024
2023 financial statements
Annual financial reports3.23 MB • March, 7th 2024
Elis closes the acquisition of Moderna Holding BV in the Netherlands
Press releases50.31 KB • February, 26th 2024
Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 01 2024
Voting rights75.69 KB • February, 22nd 2024
Full-year 2023 revenue (presentation)
Financial presentations2.67 MB • January, 30th 2024
Full-year 2023 revenue (press release)
Financial releases191.13 KB • January, 30th 2024
Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 12 2023
Voting rights61.25 KB • January, 17th 2024
Elis announces the signing of an agreement for the acquisition of Moderna Holding BV in the Netherlands
Press releases92.87 KB • January, 10th 2024
Termination and implementation of the liquidity contract
Share buy-back programs and liquidity contract58.38 KB • January, 2nd 2024